Medindia

X

Indian Supreme Court Dismisses Novartis’ Patent Claim for Its Cancer Drug

by Kathy Jones on  April 1, 2013 at 6:05 PM Medico Legal News   - G J E 4
Swiss pharmaceutical giants Novartis has received a huge blow to its Indian operations after the country's Supreme Court dismissed a patent request for its cancer drug, Glivec.
 Indian Supreme Court Dismisses Novartis’ Patent Claim for Its Cancer Drug
Indian Supreme Court Dismisses Novartis’ Patent Claim for Its Cancer Drug
Advertisement

The Supreme Court ruled that the compound for which Novartis was seeking a patent "did not satisfy the test of novelty or inventiveness" required by Indian law.

Advertisement
Source: AFP
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All